ArticleRheumatology (Oxford, England)2022

Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia.

Ashley Fletcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.